Structure-activity relationship of C4-substituted pyrimidopyrimidines; Dual KDR/FGFR tyrosine kinase inhibitors.

被引：0
|
作者：
Rossman, P
Luk, K
Chen, Y
Garafalo, L
Graves, B
Jackson, N
Kabat, M
Konzelmann, F
Liu, JJ
Lukacs, C
McDermott, L
Michoud, C
Portland, L
Roberts, J
Schutt, A
Simcox, M
So, SS
Tamborini, B
Yang, H
机构：
[1] Hoffmann La Roche Inc, Discovery Chem, Nutley, NJ 07110 USA
[2] Hoffmann La Roche Inc, Chem Synth, Nutley, NJ 07110 USA
[3] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ 07110 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
124-MEDI
引用
收藏
页码：U129 / U129
页数：1
相关论文
共 50 条
  • [41] Lysine derivatives as potent HIV protease inhibitors.: Discovery, synthesis and structure-activity relationship studies
    Bouzide, A
    Sauvé, G
    Yelle, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) : 1509 - 1513
  • [42] ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors
    Bandarage, Upul K.
    Court, John
    Gao, Huai
    Nanthakumar, Suganthini
    Come, Jon H.
    Giroux, Simon
    Green, Jeremy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 33
  • [43] Studies on 5-lipoxygenase inhibitors. Synthesis of and structure-activity relationship in p-hydroxyarylalkenylbenzoazoles
    Kosaka, T
    Ochiai, K
    Ohba, S
    Wakabayashi, T
    Murota, S
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1997, 117 (09): : 611 - 617
  • [44] Design, synthesis, and structure-activity relationship studies of novel cyclin dependent kinases (CDKS) inhibitors.
    Tedder, ME
    Dumas, DP
    Sang, CS
    Coulter, D
    Yang, JY
    Chen, XH
    Cao, XD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U653 - U653
  • [45] Quantitative Structure-Activity Relationship Study on Pyrrolotriazine Derivatives as Met Kinase Inhibitors
    Sharma, B. K.
    Yashwant
    Srivastava, B.
    ASIAN JOURNAL OF CHEMISTRY, 2010, 22 (10) : 8231 - 8245
  • [46] Cyclic Peptides as Protein Kinase Inhibitors: Structure-Activity Relationship and Molecular Modeling
    Sanner, Michel F.
    Zoghebi, Khalid
    Hanna, Samara
    Mozaffari, Saghar
    Rahighi, Simin
    Tiwari, Rakesh K.
    Parang, Keykavous
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (06) : 3015 - 3026
  • [47] Structure-activity relationship (SAR) and in vivo activity of a novel series of C5-substituted anilinoquinazolines with highly potent and selective inhibition of c-Src tyrosine kinase activity.
    Hennequin, LF
    Van der Brempt, CL
    Morgentin, R
    Olivier, A
    Plé, PA
    Allen, J
    Costello, GF
    Curwen, J
    Fennell, M
    Green, TP
    Jacobs, V
    Whittaker, R
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6183S - 6184S
  • [48] Implication of molecular docking in the study of structure-activity relationship of receptor tyrosine kinases inhibitors
    Mashkani, Baratali
    Ashman, Leonie
    Griffith, Renate
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S31 - S32
  • [49] Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase
    Cheney, I. Wayne
    Yan, Shunqi
    Appleby, Todd
    Walker, Hell
    Vo, Todd
    Yao, Nanhua
    Hamatake, Robert
    Hong, Zhi
    Wu, Jim Z.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (06) : 1679 - 1683
  • [50] Structure-activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphatase
    Anantharajan, Jothi
    Baburajendran, Nithya
    Lin, Grace
    Loh, Yong Yao
    Xu, Weijun
    Ahmad, Nur Huda Binte
    Liu, Shuang
    Jasson, Anna E.
    Kuan, John Wee Liang
    Ng, Elizabeth Yihui
    Yeo, Yee Khoon
    Hung, Alvin W.
    Joy, Joma
    Hill, Jeffrey
    Ford, Heide L.
    Zhao, Rui
    Keller, Thomas H.
    Kang, CongBao
    PROTEIN SCIENCE, 2022, 31 (02) : 422 - 431
12345